Many users are left to pay for GLP-1 weight loss medications, which can cost more than $1,000 per month, out of pocket
We know from randomised clinical trials that they have positive effects, but clinical reality is different with patients varying in disease severity, comorbidities, and adherence to treatment recommendations, says Bjrn Pasternak
Comparing Safety Profiles: Melanotan I vs II On paper, Melanotan I has the more favorable safety profile, and the reasons are straightforward: receptor selectivity, dosing route, and regulatory oversight
When sleep quality declines, stress hormones such as cortisol may increase, which can make the body more sensitive to nausea or gastrointestinal discomfort
Inflammatory bowel disease management differs between ulcerative colitis and Crohn's disease